TODAY'S HEADLINES

Cheaper generic EpiPen doesn't quiet critics

Despite offering a generic version of its EpiPen, Mylan has been unable to curb the backlash that began in late August over the cost of its epinephrine injection. Behind the flap

Abuse-deterrent opioid pain drug approved

Pfizer recently received FDA approval for oxycodone/naltrexone (Troxyca ER) extended-release capsules for treating severe pain, which has properties that are expected to reduce abuse when crushed and administered by oral and intranasal routes. Read more

CONTINUING PHARMACY EDUCATION

Interventions to improve quality of life for patients with psoriasis and psoriatic arthritis

This month's CE activity, "Interventions to improve quality of life for patients with psoriasis and psoriatic arthritis," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians about pharmacist intervention in improving the quality of life for patients with psoriasis and psoriatic arthritis.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

First generic Nasonex available

The manufacturer of the first generic version of Nasonex nasal spray (mometasone furoate monohydrate) stands to make millions of dollars from the drug. Here's why

September 07, 2016

Related Articles

EpiPen discounts offered after pricing flap

CDC issues opioid-prescribing guidelines